AsttraZeneca Pharmaceuticals LP recalls Airsupra (albuterol and budesonide) inhalation aerosol
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Defective delivery system
- Products
-
- Airsupra (albuterol and budesonide) inhalation aerosol
- Company
- AsttraZeneca Pharmaceuticals LP
- Where it was sold
-
USA Nationwide
Nationwide
- Units affected
- a) 807,837 canisters; b) 235,698 canisters
- About this recall
- Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France, .